Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
173 Results for "
complement protein
" in MedChemExpress (MCE) Product Catalog:
Products (173)
173 Results for "complement protein" in MCE Product Catalog:
1
1 Cited Publications
Cat. No.: HY-P76185
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: C1QBP; Splicing Factor SF2-Associated protein; Prev. HABP1; ASF/SF2-Associated protein P32; complement Component 1 Q Subcomponent-Binding protein, Mitochondrial; Glycoprotein GC1qBP; Mitochondrial Matrix protein P32; SF2AP32; Hyaluronan-Binding protein 1
Species:
Mouse
Source:
E. coli
Cat. No.: HY-NP004
Synonyms: CVF
Synonyms: N-Acetyl-L-serine
Cat. No.: HY-P99050
CAS No.: 2049079-64-1
Synonyms: BIVV009; IPN-009; TNT009
Target:
Research Areas:
Cat. No.: HY-P99365
CAS No.: 1803171-55-2
Synonyms: ALXN1210
Target:
Research Areas:
Cat. No.: HY-NP0194A
and non-immune cells. C1q Protein (mouse) can be used for the research of mutiple disease .
Cat. No.: HY-P11329
CAS No.: 862973-56-6
Target:
Research Areas:
Cat. No.: HY-145720
CAS No.: 1639264-46-2
Synonyms: ALN-CC5
Research Areas:
Cemdisiran (ALN-CC5) is an N-acetylgalactosamine-conjugated RNAi agent and also a complement component C5 inhibitor. Cemdisiran targets C5 mRNA, cleaves C5 mRNA via the endogenous RNA interference pathway, and inhibits the production of C5 protein in the liver. Cemdisiran exerts a dose-dependent inhibitory effect on total C5 concentrations in cynomolgus monkeys. When used in combination with Pozelimab (HY-P99786) in cynomolgus monkeys, Cemdisiran achieves a more sustained and complete inhibitory effect on complement activity. Cemdisiran can be used in the research of paroxysmal nocturnal hemoglobinuria and other complement-mediated diseases .
Cat. No.: HY-P10633
CAS No.: 1628913-44-9
Target:
Research Areas:
Cat. No.: HY-P99638
CAS No.: 2456407-94-4
Synonyms: ALXN-1720
Target:
Research Areas:
Cat. No.: HY-P1823
CAS No.: 147516-85-6
Research Areas:
Infection Cardiovascular Disease Metabolic Disease Inflammation/Immunology Cancer
Cat. No.: HY-145720A
Purity: 96.02%
Synonyms: ALN-CC5 sodium
Research Areas:
Cemdisiran sodium (ALN-CC5 sodium) is an N-acetylgalactosamine-conjugated RNAi agent and also a complement component C5 inhibitor. Cemdisiran sodium targets C5 mRNA, cleaves C5 mRNA via the endogenous RNA interference pathway, and inhibits the production of C5 protein in the liver. Cemdisiran sodium exerts a dose-dependent inhibitory effect on total C5 concentrations in cynomolgus monkeys. When used in combination with Pozelimab (HY-P99786) in cynomolgus monkeys, Cemdisiran sodium achieves a more sustained and complete inhibitory effect on complement activity. Cemdisiran sodium can be used in the research of paroxysmal nocturnal hemoglobinuria and other complement-mediated diseases .
Cat. No.: HY-NP0194C
and non-immune cells. C1q Protein (rat) can be used for the research of mutiple disease .
Cat. No.: HY-P991067
CAS No.: 2724922-85-2
Synonyms: KP-104
Target:
Research Areas:
Cat. No.: HY-P1345
CAS No.: 869988-94-3
Target:
Research Areas:
Research Areas:
Activated DPG Subunit can be used in the synthesis of exon jumping oligomer conjugates. The oligomer conjugates complement selected target sites in the human anti-muscular atrophy protein gene and induce exon 51 jumping. It can be used for research of muscular dystrophy .
Target:
Research Areas:
Activated T Subunit can be used in the synthesis of exon jumping oligomer conjugates. The oligomer conjugates complement selected target sites in the human anti-muscular atrophy protein gene and induce exon 51 jumping. Activated T subunit can be used for research of muscular dystrophy .
Cat. No.: HY-P99767
CAS No.: 2210314-30-8
Synonyms: ALXN1007; Lendalizumab
Target:
Research Areas:
Cat. No.: HY-NP0194B
and non-immune cells. C1q Protein (rabbit) can be used for the research of mutiple disease .
Cat. No.: HY-P2969
CAS No.: 80295-66-5
Target:
Research Areas:
Complement factor I is a serine protease that downregulates complement activity in the fluid phase and/or on cell surfaces in conjunction with one of its cofactors, factor H (FH), complement receptor 1 (CR1/CD35), C4 binding protein (C4BP) or membrane cofactor protein (MCP/CD46) .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
